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Summary
Endogenousmodulators of the central melanocortin system, such as the agouti-related protein (AgRP), should hold a pivotal
position in the regulation of energy intake and expenditure. Despite this, AgRP-deficient mice were recently reported to
exhibit normal food intake, body weight gain, and energy expenditure. Here we demonstrate that 2- to 3-month-old Agrp
null mice do in fact exhibit subtle changes in response to feeding challenges (fasting and MCR agonists) but, of more signif-
icance andmagnitude, exhibit reduced bodyweight and adiposity after 6months of age. This age-dependent lean phenotype
is correlated with increasedmetabolic rate, body temperature, and locomotor activity and increased circulating thyroid hor-
mone (T4 and T3) and BAT UCP-1 expression. These results provide further proof of the importance of the AgRP neuronal
system in the regulation of energy homeostasis.Introduction
The central melanocortin (MC) system is proposed as a critical
regulator of food intake, energy expenditure, and neuroendo-
crine function. The case for the involvement of the melanocortin
4 receptor (MC4-R) is primarily from the presence of severe obe-
sity in both mouse genetic deletion studies (Huszar et al., 1997)
and naturally occurringmutations in humans (Vaisse et al., 1998;
Yeo et al., 1998). Further evidence has come from the agouti (Ay)
mouse model, where inappropriate central expression antago-
nizes the MC receptors and results in a maturity-onset obesity
phenotype (Lu et al., 1994). These studies stimulated the search
for closely related proteins to agouti, resulting in the identifica-
tion and cloning of the agouti-related protein (AgRP; Ollmann
et al., 1997). It was quickly demonstrated that AgRP expres-
sion wasmainly confined to the arcuate nucleus of the hypothal-
amus (Shutter et al., 1997; Ollmann et al., 1997), invariably co-
expressed with neuropeptide Y (NPY) (Broberger et al., 1998),
andAgRP-positive neuronsprojected tomanyof the samehypo-
thalamic sites to which arcuate nucleus pro-opiomelanocortin
(POMC) neurons project (Broberger et al., 1998; Haskell-
Luevano et al. 1999). The balance between the agonist action
of a-melanocyte-stimulating hormone (a-MSH) derived from
POMC and the antagonist effects of AgRP is believed to deter-
mine the final activation state of the targetMC receptors. Consis-
tent with this idea, the transgenic overexpression of AgRP reca-
pitulated the obesity syndrome observed in Ay mouse model.
At the present time, there are an abundance of hyperphagic
and obesity phenotypes (e.g., leptin receptor, POMC, and
MC4-R) observed inmicewith geneticmodifications that disrupt
the ‘‘catabolic’’ pathway (Halaas et al., 1995; Huszar et al., 1997,
Yaswen et al., 1999), but little or no phenotypes are observed in
mice deficient in the anabolic peptides, NPY, and/or AgRP
(Erickson et al., 1996; Qian et al., 2002). These observations
have led to the hypothesis that there is an inherent bias in theCELL METABOLISM : DECEMBER 2005 $ VOL. 2 $COPYRIGHT ª 2005 Eenergy homeostasis system toward weight gain, accounting for
the prevalence of obesity. However, even if considerable redun-
dancy exists in the regulation of energy intake by anabolic pep-
tides, it is still possible that deletion of a negative regulator of the
catabolic MC system might reveal specific changes in energy
expenditure. Indeed, recent studies that successfully ablated
specific adult cell population in a temporal manner have demon-
strated that AgRP/NPY neurons are necessary regulators for
normal feeding behavior (Bewick et al., 2005; Gropp et al.,
2005; Luquet et al., 2005). Complimenting those findings, we
demonstrate that small changes in feeding behavior are present
even in young adult Agrp null mice, but more importantly, we
demonstrate there is significant impairment in the regulation of
body weight with aging of Agrp null mice.
Results
Targeted disruption and reporter gene expression
from the Agrp locus
Agrp2/2 mice were generated by constructing and utilizing
BAC-based targeting vectors (Valenzuela et al., 2003) with dele-
tion of the entire Agrp coding and insertion of a lacZ reporter
gene as well as a neomycin-selection cassette (see Figure S1
in the Supplemental Data available with this article online). Anal-
ysis of hypothalamic neuropeptide mRNA expression in mice of
12weeks of age byNorthern blot analysis confirmed the specific
ablation of Agrp mRNA under both ad libitum conditions and
after fasting, which is known to elicit a dramatic increase in Agrp
expression (Figure S2). No compensatory increase was de-
tected in the mRNA expression of the orexigenic neuropeptides
NPY or MCH; however we did observe approximately a 50%
decrease in the basal mRNA expression of neuropeptide Vgf
(Figure S2). Fasting of Agrp+/+ and Agrp2/2 mice produced an
equivalent increment in the expression of NPY and MCH andLSEVIER INC. DOI 10.1016/j.cmet.2005.11.004 421
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pression of Vgf observed between the Agrp+/+ and Agrp2/2
mice was lost (Figure S2). Reporter expression was detected
specifically in neurons of the arcuate nucleus and median emi-
nence of the hypothalamus (Figure 1A), but not elsewhere in
the brain. Numerous cells in the adrenal medulla (Figure 1B)
also exhibited specific reporter expression. Additional expres-
sion was observed in the kidney in glomeruli-like structures
(data not shown), consistent with previous reports of endoge-
nous AgRP (Shutter et al., 1997), although no functional distur-
bance in kidney function (serum creatinine; data not shown)
could be detected in Agrp2/2 mice.
Agrp deletion does not impair metabolic
parameters in young mice
Analysis in F2 generation mice revealed that Agrp2/2mice were
viable and displayed no significant differences in the body
weights of male or female as compared to their Agrp+/+ litter-
mates (Figure 2A). Consistent with this, there were no significant
differences in 24 hr food intake (Figure 2B) or metabolic rate, as
assessed by oxygen consumption (VO2, Figure 2C), respiratory
quotient, or energy expenditure (data not shown) in mice at 8–10
weeks of age. Locomotor activity was also similar between both
groups of mice (Figure 2D).
Since changes in the expression of hypothalamic orexigenic
neuropeptides, including Agrp, are thought to have important
physiological consequences, such as stimulating reflex hyper-
phagia following a fast, we were interested in monitoring this re-
sponse in the Agrp2/2mice. Following a 24 hr fast, Agrp+/+mice
showed a small but significant increase in food intake at 1, 4, and
24 hr during the re-feeding period (data not shown). In contrast,
the Agrp2/2 mice showed no significant increase in food intake
at 1 or 4 hr post-fast. Food intake in the Agrp2/2 mice was sig-
nificantly increased at 24 hr post-fast, although to a lesser extent
than in the Agrp+/+ mice (data not shown). Once again, the met-
abolic parameters (VO2, respiratory quotient, and locomotor ac-
tivity) during and after this period of food deprivation did not sig-
nificantly differ between groups (data not shown). Body weights
of the Agrp+/+and Agrp2/2 mice at the start of the fast (Agrp+/+:
21.16 0.51 versus Agrp2/2: 21.616 0.76) and at the end of the
re-feeding period (Agrp+/+: 20.25 6 0.66 versus Agrp2/2: 20.78
g) were also similar.
If AgRP is indeed the endogenous antagonist of the melano-
cortin system then its absence should cause a potentiated ano-
rectic response induced by receptor agonists. To directly evalu-
ate this, Agrp2/2 mice and Agrp+/+ littermates were placed in
metabolic cages and administered the melanocortin agonist,
melanotan II (MT-II; 3 mg/kg i.p.), or phosphate-buffered saline
(PBS) 2 hr before the onset of dark phase of the light cycle. In
Agrp+/+ mice, MT-II potently inhibited food intake during the first
1–4 hr of the nocturnal feeding period. This effect rapidly atten-
uated over time such that in Agrp+/+ mice cumulative 24 hr food
intake in MT-II-treated animals was not significantly different
from intake in those injected with PBS (Figure 3A, ANOVA:
F1,21 = 0.383; NS). The magnitude of the same dose of MT-II
on food intake was similar in Agrp2/2 mice over the first 4 hr of
the dark period but was of prolonged duration (Figure 3B) such
that cumulative food intake at 24 hr was significantly reduced
(ANOVA effect of time x treatment: F1,21 = 4.236; p < 0.0001).
In addition, repeated administration of 3 mg/kg MT-II for 4
consecutive days prevented Agrp2/2 mice from gaining weight422over the 4 day period (Figure 3C, effect of time x genotype: F1,4 =
6.54; p = 0.0005). Whereas central administration of MT-II po-
tently induces body weight loss, this chronic peripheral dosing
regimen of MT-II was based on a previous study (Pierroz et al.,
2002) and was intended to create a submaximal stimulation of
the melanocortin pathway that would reveal a difference in sen-
sitivity to melanocortin receptor stimulation in the KO mice. We
also tested the anorectic response induced by the serotonin-
releasing agent, fenfluramine, which mediates its anorectic ef-
fect by its action on melanocortin neurons in the hypothalamus
(Heisler et al., 2002). Under these test conditions, Agrp+/+ mice
showed only a modest reduction in food intake at 1 or 4 hr into
the dark period or after 24 hr (NS at any time point). In contrast,
Agrp2/2 mice exhibited a strong suppression of food intake at
1 hr into the dark period, which was statistically significant
(data not shown), and interestingly, these mice appeared to
compensate for the anorectic response by overeating at 24 hr.
Agrp2/2mice did not exhibit a general hypersensitivity to all an-
orectic compounds, as the effects of PYY(3–36) and CCK were
equally variable inAgrp+/+ andAgrp2/2mice using the same test
paradigm (data not shown).
Figure 1. Expression analysis of the lacZ reporter gene in the endogenous Agrp
loci
A) Staining of whole brain and coronal sections reveals specific reporter gene ex-
pression (lacZ reporter, in blue) of neurons in the arcuate nucleus of Agrp2/2mice.
B) Analysis of whole adrenal gland and sections revealed lacZ reporter expression
in the medulla (M) of the adrenal gland.CELL METABOLISM : DECEMBER 2005
Age-related lean phenotype in AgRP KO miceFigure 2. 8- to 10-week-old Agrp null mice display
no deficit in metabolic parameters
No differences in (A) body weight (top left), (B) spon-
taneous food intake (top right), (C) basal metabolic
rate (oxygen consumption), and (D) locomotor activ-
ity were evident in male or female (data not shown)
Agrp2/2mice at 8–10 weeks of age. Data points rep-
resent the mean 6 SEM, n = 8/genotype.Agrp2/2 mice exhibit reduced body weight and elevated
metabolic rate with age
Since the lack of effect of AgRP deletion on body weight and
spontaneous food intake was surprising, given the potent ef-
fects of exogenous AgRP on food intake and adiposity (Ollmann
et al., 1997), we backcrossed heterozygote mice to C57BL6/J
mice for five generations (which represents 96.9% C57BL6/J
background strain). Both backcrossed Agrp+/+ and Agrp2/2
mice showed no significant differences in body weight at 3–5
months of age, similar to the results from F2 generation mice
shown above. However, at 6 months of age, male Agrp2/2
mice showed a statistically significant reduction in body weight,
which became more pronounced as the animals aged
(Figure 4A, ANOVA effect of time x genotype over 12 months:
F1, 25 = 7.09; p < 0.0001). Although body weight was decreased,
no difference in body length was apparent between Agrp+/+ and
Agrp2/2 mice (Figure 4A). We examined metabolic parameters
in these mice at 10 months of age. Consistent with their reduc-
tion in body weight, Agrp2/2 mice exhibited a significant in-
crease in metabolic rate (VO2) during the dark phase of the light
cycle (Figure 4B), a significant reduction in respiratory quotient
during the light phase, indicating greater lipid utilization
(Figure 4C, ANOVA effect of time x genotype: F1, 26 = 2.25; p =
0.0007), and a significant increase in energy expenditure (data
not shown). Locomotor activity was also increased in Agrp2/2
mice during the dark phase (Figure 4D, ANOVA effect of time x
genotype: F1, 26 = 1.57; p = 0.0411). The reduction in body
weight in the 10-month-old Agrp2/2 mice was primarily due to
a significant reduction in body fat mass, while lean mass re-
mained unchanged (Figure 4E and data not shown). Absolute
food intake was not altered in Agrp2/2 mice (average intake
over 4 days: Agrp+/+, 5.8 6 0.2 g versus Agrp2/2, 5.4 6 0.2 g,
NS) even when corrected for body weight (Agrp+/+, 0.165 6
0.0054 g/g body weight versus Agrp2/2, 0.177 6 0.0046 g/g
body weight, NS). Core body temperature was increased inCELL METABOLISM : DECEMBER 2005a separate cohort of 12-month-old Agrp2/2 mice compared to
age-matched control mice (Figure 4F). An analysis of serum
did reveal a marked increase in thyroid hormone levels (total
T3 and T4) in both male and female Agrp2/2 mice compared
Figure 3. Agrp deletion alters the response to melanocortin agonist challenges
Detailed assessment of food intake following an acute MT-II injection (3.0 mg/kg
i.p.) showed that (B) Agrp2/2mice exhibit a more pronounced decrease in food in-
take over the following 24 hr than (A) Agrp+/+ mice (wt). In a separate experiment,
prolonged administration of MT-II (3 mg/kg/day, i.p. for 4 days) significantly re-
duced body weight (C). Data points represent the mean 6 SEM, n = 8/genotype.423
S H O R T A R T I C L EFigure 4. Aging Agrp-deficient mice are lean and
exhibit reduced adiposity but increased thyroid hor-
mone levels
A) Body weight, but not body length (insert), was ob-
served to be significantly reduced in Agrp2/2 (N5F2
generation) male mice from 6 months of age on-
ward. Metabolic analysis revealed (B) significantly
increased oxygen consumption (dark period), (C) re-
duced respiratory quotient (light period), and (D) ele-
vated locomotor activity in 10-month-old Agrp2/2
mice compared to Agrp+/+ littermates. (E) Absolute
fat mass was significantly reduced in 10-month-old
Agrp2/2mice compared to Agrp+/+ littermates, while
leanmass was unchanged from analysis by PIXimus.
For (A)–(E), *p < 0.05, zp < 0.01, and the data points
represent the mean 6 SEM of n = 5 Agrp+/+ and 8
Agrp2/2 male mice. F) Body temperature was in-
creased in male 12-month-old Agrp2/2 mice. *p <
0.05 and the data points represent the mean 6
SEM of n = 9 Agrp+/+ and 5 Agrp2/2 male mice. G)
Analyses of serum samples showed an increase in
basal (4 hr fast) circulating total T3 and (H) total T4
in 10-month-old male Agrp2/2 mice compared to
Agrp+/+ littermates. *p < 0.05, zp < 0.01. The data
points represent the mean 6 SEM of n = 5 Agrp+/+
and 8 Agrp2/2 male mice.to Agrp+/+ littermates (Figure 4G and 4H). Consistent with the
marked reduction in adiposity, Agrp2/2 mice also showed an
approximately 3-fold decrease in circulating leptin levels (data
not shown). Cholesterol levels were also significantly reduced
in both male and female Agrp2/2 mice, whereas insulin, gluca-
gon, glucose, triglycerides, nonesterified fatty acids (NEFA),
and corticosterone remained unchanged (Table S1).
Discussion
We demonstrate here that Agrp null mice do have small but
detectable changes in feeding responses, but more importantly
they develop a late-onset lean phenotype that is associated with
increased energy expenditure. The fact that this is also associ-424ated with an increased T3/T4 lends support for the hypothesis
that the MC system utilizes the HPT axis as a critical part of its
repertoire to balance energy homeostasis (Kim et al., 2000; Fe-
kete et al., 2002) and may have important implications in our un-
derstanding and treatment of mature-onset obesity in humans.
These results are consistent with recent AgRP-specific neuronal
ablation (toxin-induced) studies that have clearly demonstrated
the importance of NPY/AgRP neuronal system to the adult ani-
mal for the normal regulation of food intake and body weight
(Gropp et al., 2005, Luquet et al., 2005).
The disparity between the behavioral effects observed with
exogenous administration of AgRP and the phenotype of Agrp
null mouse lines (Qian et al., 2002) has largely been ascribed
to developmental compensatory mechanisms. Perhaps moreCELL METABOLISM : DECEMBER 2005
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ported by Luquet et al., 2005, where only neonates and not adult
mice are able to withstand toxin-induced AgRP neuronal abla-
tion without becoming moribund. Whatever the nature of the
compensation mechanism(s), Agrp null mice commonly show
no differences in body weight, basal spontaneous food intake,
or metabolic parameters between the different lines in mice 2–
3 months of age. In contrast, we do demonstrate here that
Agrp2/2 mice exhibit impaired behavioral responses to certain
stresses, such as reflexive hyperphagia. One variable that may
have previously masked this effect might be the severity of the
fasting paradigm, bringing into play additional compensatory
pathways; e.g., in our studies we observe a normalization of
Vgf in Agrp2/2 mice with prolonged fasting. Similar discrepan-
cies in the detection and magnitude of a reflexive hyperphagic
response have also been reported in the evaluation of Npy2/2
mice (Bannon et al., 2000; Segal-Lieberman et al., 2003) and
have been attributed to parameters such as the timing of fast-
ing/refeeding. Both experiments were conducted with mice of
similar mixed background (129/C57Bl6), so if any difference ex-
ists it may lie at a more molecular level since we do note that dif-
ferent ES cells were used to generate these lines. Whatever the
cause, it is clear that AgRP, like NPY, can play a role in modulat-
ing re-feeding responses under certain situations (mild stress),
but the magnitude of these effects is small.
A wealth of data exists documenting the actions of AgRP on
MC receptors both in vivo and in vitro (Ollmann et al., 1997),
and as such a reduction in endogenous AgRP levels should be
correlated with enhanced action of MC ligands or pharmacolog-
ical mimetics. Indeed, a prolonged sensitivity to the anorectic
actions of MT-II was observed in Agrp null mice. The idea of
an increase in MC receptor tone is further supported by the find-
ing that fenfluramine, which is believed to activate POMC neu-
rons in the arcuate nucleus via its action on 5-HT2C receptors,
reduced food intake in free-fed Agrp2/2 but not in Agrp+/+
mice at this dose. It is interesting to note that with AgRP cell ab-
lation technique (Gropp et al., 2005), there is a clear increase in
POMCexpression (Gropp et al., 2005), suggesting a clear loss of
NPY/AgRP inhibitory input. Whether this is evident in the Agrp
null line reported in these studies has not been determined.
Whereas the phenotype of 2- to 3-month-old Agrp2/2 mice
was revealed only when the mice were presented with a physio-
logical or pharmacological challenge, 6-month-old Agrp2/2
mice exhibited a spontaneous reduction in body weight and
body fat mass. The reduction in body weight was progressive,
such that at 12 months of age, the Agrp2/2mice were 13% ligh-
ter than theirAgrp+/+ littermates. Themagnitude and direction of
this effect on body weight is consistent with the AgRP/NPY neu-
ronal ablation studies (Bewick et al., 2005; Luquet et al., 2005)
and opposite to that for the deletion of POMC neurons (Gropp
et al., 2005). Our studies into the physiological basis of this
lean phenotype show it is associated with elevated circulating
levels of T3 and T4 and suggest that the absence of AgRP
may play some role in modulating the activity of the HPT axis.
Such a phenomenon would be consistent with previous studies
showing that NPY/AgRP neurons send inhibitory projections
onto paraventricular TRH neurons (Diano et al., 1998), that exog-
enous AgRP administration has a central inhibitory action on the
HPT axis (Fekete et al., 2002), and that this effect of AgRP is ab-
sent in MC4-R KC mice (Fekete et al., 2004). Consistent with
their lean phenotype, indirect calorimetry studies revealed an in-CELL METABOLISM : DECEMBER 2005crease in lipid utilization in the aging Agrp2/2 mice specifically
during the resting phase of the light/dark cycle, when animals
switch to lipid substrate utilization. Oxygen consumption was
also increased in the aging Agrp2/2 mice, specifically during
the active period, when animals require more oxygen for physi-
cal activity. These findings are indicative of sympathetic nervous
system activation, which is a well-documented effect of in-
creased thyroid function (Silva, 1995). Both UCP-1 mRNA ex-
pression in brown adipose tissue and core body temperature
were also increased in Agrp2/2 mice, supporting an increased
activation of the sympathetic nervous system and subsequent
increased metabolic rate and energy expenditure.
In parallel with indirect calorimetry, we monitored locomotor
activity of the Agrp2/2 mice. Compared with Agrp+/+ mice,
Agrp2/2 mice showed increased activity specifically during the
active phase of the light-dark period, consistent with the in-
crease in oxygen consumption seen during this period. Until re-
cently, little was known about the contribution of spontaneous
activity and non-exercise activity thermogenesis (NEAT) to en-
ergy expenditure. Studies with other hyperthyroid animals
(Levine et al., 2003) identified specific changes in spontaneous
activity that are consistent with our findings in Agrp2/2 mice
and opposite in direction to the recently documented effect of
exogenous AgRP administration to reduce locomotor activity
(Tang-Christensen et al., 2004). Pronounced hyperphagia is of-
ten associated with hyperthyroidism, although we observed no
change in absolute intake and only a small difference in food in-
take per gram of body weight. The absence of changes in food
intake in this setting, however, may be indicative of the relatively
mild activation of the thyroid axis, consistent with our previous
observations (Macdonald et al., 2005).
Of interest in the present study is the finding that the lean phe-
notype of the Agrp2/2mice and the associated changes in met-
abolic parameters only presented themselves in agingmice. Ag-
ing in rodents is associated with increased adiposity, leptin
resistance (Gabriely et al., 2002; Zhang et al., 2004), and de-
creased thyroid function (Pekary et al., 1987; Waner and Nyska
1988; Penzes et al., 1991). Thus, it would seem that with the de-
letion of AgRP,mice are able tomaintain their thyroid function as
they age and subsequently maintain metabolic parameters such
as oxygen consumption, which would allow the maintenance of
a lean body composition.
In summary, we show that genetic deletion of AgRP eventually
leads to the maintenance of a lean phenotype in aging mice.
These findings, along with the association recently found be-
tween leanness and polymorphisms in the human AgRP gene
(Marks et al., 2004) suggest that effective treatment of obesity
and related metabolic disorders by modulation of the melano-
cortin system may require both the inhibition of endogenous
AgRP as well as the administration of an MC3/4-R agonist.
Experimental procedures
Generation of Agrp-deficient mice and experimental procedures
Mice were generated using bacterial artificial chromosome (BAC)-based tar-
geting vectors, in which the coding region of the Agrp locus (from ATG initi-
ation codon to the termination codon) was precisely deleted and replaced
with an in-frame lacZ reporter gene and neomycin-selectable marker, and
electroporated into embryonic stem (ES) cells. After germline transmission
was established, F1 heterozygous mice were bred together to generate F2
Agrp+/+ and Agrp2/2 mice. Also, mice were repeatedly backcrossed to
C57BL6/J to generate N5 breeding heterozygote pairs that were used to425
S H O R T A R T I C L Egenerate N5F2 Agrp+/+ and Agrp2/2 mice. All experiments reported were
conducted on either F2 or N5F2 littermates that were housed under 12 hr
of light per day in a temperature-controlled environment. All procedures
were conducted in compliance with protocols approved by the Regeneron
Institutional Animal Care and Use Committee. Animals had free access to
standard chow (Purina # 5020; St Louis, MO). All drugs were dissolved in
sterile PBS and injected either s.c. or i.p., as indicated, 2 hr before dark onset.
MT-II was obtained from BachemBioscience Inc. (King of Prussia, PA). All in-
jection studies were carried out in freely feeding mice.
Indirect calorimetry, food intake, and body composition
Metabolic parameters were obtained using an Oxymax (Columbus Instru-
ments International Corp., Columbus, OH) open circuit indirect calorimetry
system, and body composition by dual emission X-ray absorption (PIXImus;
Lunar, Madison, WI) by previously described methods (Macdonald et al.,
2005).
Serum chemistry and tissue analysis
Basal serum samples were taken between 14:00 and 14:30 hr and analyzed
for glucose, triglycerides, and cholesterol utilizing the Bayer 1650 blood
chemistry analyzer (Bayer, Tarrytown, NY). Nonesterified free fatty acids
(NEFA) were analyzed using a diagnostic kit (WAKO, Richmond, VA). Insulin,
leptin, and glucagon were assessed using the Mouse Endocrine Immunoas-
say Panel (LincoPlex, Linco, St. Charles, MO). T3 and T4 were measured us-
ing T3 (total) and T4 (total) EIA kits from Alpco Diagnostics (Windham, NH).
Corticosterone was assessed using a corticosterone EIA kit from R & D sys-
tems (Minneapolis, MN). Serum was diluted 1:16 for corticosterone analysis.
Histology
For b-galactosidase staining, adult mice were deeply anesthetized (240 mg/
kg ketamine, 48 mg/kg xylazine, i.m.) and exsanguinated with ice-cold hep-
arinized saline. Tissue was fixed by transcardial perfusion of 2% paraformal-
dehyde in 0.1 M phosphate buffer, postfixed for 2 hr and then cryoprotected
for at least 24 hr in two changes of buffered 30%sucrose at 4ºCwith agitation
before sectioning.
Data and statistical analyses
Data are expressed as mean 6 SEM and comparisons carried out using
a paired or unpaired t test or repeated measures analysis of variance
(ANOVA) where appropriate using the program STATVIEW. When a signifi-
cant F ratio was obtained (significance p < 0.05), post hoc analysis was con-
ducted between groups using a multiple comparison procedure with Bonfer-
roni/Dunn post hoc comparison. p values < 0.05 were considered significant.
Supplemental data
Supplemental data include four figures and one table and are available with
this article online at http://www.cellmetabolism.org/cgi/content/full/2/6/421/
DC1/.
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